zoledronic acid — Patent Landscape

Aggregated US Orange Book patent estate across every drug in the zoledronic acid class. 3 active patents protecting 1 drugs. First major cliff: 2028. Daily refresh.

1
Drugs in class
3
Active US patents
65/100
Avg vulnerability
—
Annual revenue covered

Originators

Novartis 3 patents

Cliff calendar — next 15 years

3
28

Drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Zometa
ZOLEDRONIC ACID
 Novartis 3 65 — 2028-02-05

Most attackable patents

Patent Drug Type Vuln Expiry
7932241 Zometa other 75 2028-08-05
7932241 Zometa formulation 60 2028-02-05
7932241 Zometa formulation 60 2028-02-05

Strongest defences

Patent Drug Type Vuln Expiry
7932241 Zometa formulation 60 2028-02-05
7932241 Zometa formulation 60 2028-02-05
7932241 Zometa other 75 2028-08-05

Related